Shanghai Pharmaceuticals Holding Co (HKSE:02607) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02607 Shanghai Pharmaceuticals Holding Co Ltd HKSE:02607
89 GF Score
Price HK$10.93
GF Value HK$14.99
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Shanghai Pharmaceuticals Holding Co  (HKSE:02607) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PB Ratio Related Terms


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PB Ratio Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.65 0.55 0.59 0.50

Shanghai Pharmaceuticals Holding Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.57 0.50 0.51 0.50

HKSE:02607 vs MCK, COR, CAH: Cyclically Adjusted PB Ratio Comparison

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PB Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PB Ratio falls into.


HKSE:02607
89GF Score
Shanghai Pharmaceuticals Holding Co Ltd HKSE:02607
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Shanghai Pharmaceuticals Holding Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=28.917/116.0564*116.0564
=28.917

Current CPI (Jun. 2026) = 116.0564.

Shanghai Pharmaceuticals Holding Co Quarterly Data

Book Value per Share CPI Adj_Book
201503 14.871 99.900 17.276
201506 14.863 99.500 17.336
201509 14.830 100.500 17.126
201603 15.633 102.200 17.753
201609 15.521 102.400 17.591
201703 15.904 103.200 17.885
201709 17.020 104.100 18.975
201803 19.231 105.300 21.195
201806 18.365 104.900 20.318
201809 18.373 106.600 20.003
201812 18.631 106.500 20.303
201903 19.721 107.700 21.251
201906 19.146 107.700 20.632
201909 18.846 109.800 19.920
202003 19.758 112.300 20.419
202006 19.957 110.400 20.980
202009 21.403 111.700 22.238
202012 22.836 111.500 23.769
202103 23.678 112.662 24.392
202106 24.227 111.769 25.156
202109 24.632 112.215 25.475
202112 25.423 113.108 26.086
202203 24.849 114.335 25.223
202206 24.012 114.558 24.326
202209 22.945 115.339 23.088
202212 23.685 115.116 23.879
202303 24.672 115.116 24.874
202306 22.998 114.558 23.299
202309 23.205 115.339 23.349
202312 23.881 114.781 24.146
202403 24.003 115.227 24.176
202406 23.857 114.781 24.122
202409 24.851 115.785 24.909
202412 24.035 114.893 24.278
202503 24.679 115.116 24.881
202506 26.250 114.907 26.513
202509 26.415 115.471 26.549
202512 26.968 115.832 27.020
202603 27.993 116.303 27.934
202606 28.917 116.056 28.917

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Shanghai Pharmaceuticals Holding Co (HKSE:02607) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued. The current stock price of HK$10.93 is trading 27.1% below its estimated GF Value™ of HK$14.99. GuruFocus considers Shanghai Pharmaceuticals Holding Co to be Modestly Undervalued.

Key valuation signals for HKSE:02607:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: HK$14.99 vs. price of HK$10.93 (27.1% below fair value)
  • GF Score™: 89/100 with 5 warning signs

No single metric tells the full story. See the HKSE:02607 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Pharmaceuticals Holding Co Business Description

Other Exchanges S1R:Germany601607:China
Address No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
89GF Score

Get the complete analysis for HKSE:02607

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$10.93
Price
HK$14.99
GF Value